Comparison of safety and immunogenicity of CoronaVac and ChAdOx1 against the SARS-CoV-2 circulating variants of concern (Alpha, Delta, Beta) in Thai healthcare workers

BACKGROUND: Inactivated vaccine (CoronaVac) and chimpanzee adenovirus-vector vaccine (ChAdOx1) have been widely used in resource-limited settings. However, the information on the reactogenicity and immunogenicity of these two vaccines in the same setting are limited. METHODS: Healthy health care wor...

Descripción completa

Detalles Bibliográficos
Autores principales: Angkasekwinai, Nasikarn, Sewatanon, Jaturong, Niyomnaitham, Suvimol, Phumiamorn, Supaporn, Sukapirom, Kasama, Sapsutthipas, Sompong, Sirijatuphat, Rujipas, Wittawatmongkol, Orasri, Senawong, Sansnee, Mahasirimongkol, Surakameth, Trisiriwanich, Sakalin, Chokephaibulkit, Kulkanya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896862/
https://www.ncbi.nlm.nih.gov/pubmed/35282410
http://dx.doi.org/10.1016/j.jvacx.2022.100153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896862/
https://www.ncbi.nlm.nih.gov/pubmed/35282410
http://dx.doi.org/10.1016/j.jvacx.2022.100153

Ejemplares similares